Skip to main content
Top
Published in: Familial Cancer 1/2007

01-03-2007 | Brief communication

Gastric carcinoid: germline and somatic mutation of the neurofibromatosis type 1 gene

Authors: W. Stewart, J. P. Traynor, A. Cooke, S. Griffiths, N. F. Őnen, M. Balsitis, A. A. Shah, M. Upadhyaya, E. S. Tobias

Published in: Familial Cancer | Issue 1/2007

Login to get access

Abstract

Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominantly inherited conditions. A range of complications has been described, including gastrointestinal manifestations. Gastric carcinoid tumours are associated with multiple endocrine neoplasia, atrophic gastritis and pernicious anaemia but have not been reported in NF1 in the absence of other predisposing factors. We report the occurrence and investigation of a gastric carcinoid tumour in a 23-year-old woman with previously uncomplicated NF1. Analysis of the tumour tissue revealed loss of heterozygosity at the NF1 gene locus but a normal karyotype and an absence of microsatellite instability. A germline NF1 gene nonsense mutation in exon 37 was detected by denaturing high-performance liquid chromatography and DNA sequence analysis. This is the first reported occurrence of a gastric carcinoid tumour in a patient with NF1 in the absence of other predisposing factors such as pernicious anaemia. The analyses indicate that the carcinoid arose through NF1 gene inactivation but in the absence of an inherited NF1 gene microdeletion. This case adds to the range of gastrointestinal tumours that may be encountered in patients with NF1, particularly in those who present with upper gastrointestinal haemorrhage.
Literature
1.
go back to reference Griffiths DF, Williams GT, Williams ED (1987) Duodenal carcinoid tumours, phaeochromocytoma and neurofibromatosis: islet cell tumour, phaeochromocytoma and the von Hippel-Lindau complex: two distinctive neuroendocrine syndromes. Q J Med 64:769–782PubMed Griffiths DF, Williams GT, Williams ED (1987) Duodenal carcinoid tumours, phaeochromocytoma and neurofibromatosis: islet cell tumour, phaeochromocytoma and the von Hippel-Lindau complex: two distinctive neuroendocrine syndromes. Q J Med 64:769–782PubMed
2.
go back to reference Hough DR, Chan A, Davidson H (1983) Von Recklinghausen’s disease associated with gastrointestinal carcinoid tumors. Cancer 51:2206–2208PubMedCrossRef Hough DR, Chan A, Davidson H (1983) Von Recklinghausen’s disease associated with gastrointestinal carcinoid tumors. Cancer 51:2206–2208PubMedCrossRef
3.
go back to reference Karatzas G, Kouraklis G, Karayiannakis A et al (2000) Ampullary carcinoid and jejunal stromal tumour associated with von Recklinghausen’s disease presenting as gastrointestinal bleeding and jaundice. Eur J Surg Oncol 26:428–429PubMedCrossRef Karatzas G, Kouraklis G, Karayiannakis A et al (2000) Ampullary carcinoid and jejunal stromal tumour associated with von Recklinghausen’s disease presenting as gastrointestinal bleeding and jaundice. Eur J Surg Oncol 26:428–429PubMedCrossRef
4.
go back to reference Fuller CE, Williams GT (1991) Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen’s disease). Histopathology 19:1–11PubMed Fuller CE, Williams GT (1991) Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen’s disease). Histopathology 19:1–11PubMed
5.
go back to reference Huson S (1994) Neurofibromatosis 1: a clinical and genetic overview. In: Huson S, Hughes R (eds) The neurofibromatoses: a pathogenetic and clinical overview. Chapman and Hall, London, pp 160–203 Huson S (1994) Neurofibromatosis 1: a clinical and genetic overview. In: Huson S, Hughes R (eds) The neurofibromatoses: a pathogenetic and clinical overview. Chapman and Hall, London, pp 160–203
6.
go back to reference Burke AP, Sobin LH, Shekitka KM et al (1990) Somatostatin-producing duodenal carcinoids in patients with von Recklinghausen’s neurofibromatosis. A predilection for black patients. Cancer 65:1591–1595PubMedCrossRef Burke AP, Sobin LH, Shekitka KM et al (1990) Somatostatin-producing duodenal carcinoids in patients with von Recklinghausen’s neurofibromatosis. A predilection for black patients. Cancer 65:1591–1595PubMedCrossRef
7.
go back to reference Upadhyaya M, Han S, Consoli C et al (2004) Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors. Hum Mutat 23:134–146PubMedCrossRef Upadhyaya M, Han S, Consoli C et al (2004) Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors. Hum Mutat 23:134–146PubMedCrossRef
8.
go back to reference Han SS, Cooper DN, Upadhyaya MN (2001) Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 (NF1) gene. Hum Genet 109:487–497PubMedCrossRef Han SS, Cooper DN, Upadhyaya MN (2001) Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 (NF1) gene. Hum Genet 109:487–497PubMedCrossRef
10.
go back to reference Lee HY, Garber PE (1970) Von Recklinghausen’s disease associated with pheochromocytoma and carcinoid tumor. Ohio State Med J 66:583–586PubMed Lee HY, Garber PE (1970) Von Recklinghausen’s disease associated with pheochromocytoma and carcinoid tumor. Ohio State Med J 66:583–586PubMed
11.
go back to reference Leotlela PD, Jauch A, Holtgreve-Grez H et al (2003) Genetics of neuroendocrine and carcinoid tumours. Endocr Relat Cancer 10:437–450PubMedCrossRef Leotlela PD, Jauch A, Holtgreve-Grez H et al (2003) Genetics of neuroendocrine and carcinoid tumours. Endocr Relat Cancer 10:437–450PubMedCrossRef
12.
go back to reference Wheeler MH, Curley IR, Williams ED (1986) The association of neurofibromatosis, pheochromocytoma, and somatostatin-rich duodenal carcinoid tumor. Surgery 100:1163–1169PubMed Wheeler MH, Curley IR, Williams ED (1986) The association of neurofibromatosis, pheochromocytoma, and somatostatin-rich duodenal carcinoid tumor. Surgery 100:1163–1169PubMed
13.
go back to reference Martin GA, Viskochil D, Bollag G et al (1990) The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63:843–849PubMedCrossRef Martin GA, Viskochil D, Bollag G et al (1990) The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63:843–849PubMedCrossRef
14.
go back to reference von Deimling A, Krone W, Menon AG (1995) Neurofibromatosis type 1: pathology, clinical features and molecular genetics. Brain Pathol 5:153–162 von Deimling A, Krone W, Menon AG (1995) Neurofibromatosis type 1: pathology, clinical features and molecular genetics. Brain Pathol 5:153–162
15.
go back to reference Shen MH, Harper PS, Upadhyaya M (1996) Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 33:2–17PubMedCrossRef Shen MH, Harper PS, Upadhyaya M (1996) Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 33:2–17PubMedCrossRef
16.
go back to reference John AM, Ruggieri M, Ferner R et al (2000) A search for evidence of somatic mutations in the NF1 gene. J Med Genet 37:44–49PubMedCrossRef John AM, Ruggieri M, Ferner R et al (2000) A search for evidence of somatic mutations in the NF1 gene. J Med Genet 37:44–49PubMedCrossRef
17.
go back to reference Legius E, Marchuk DA, Collins FS, Glover TW (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 3:122–126PubMedCrossRef Legius E, Marchuk DA, Collins FS, Glover TW (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 3:122–126PubMedCrossRef
18.
go back to reference Xu W, Mulligan LM, Ponder MA et al (1992) Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis. Genes Chromosomes Cancer 4:337–342PubMed Xu W, Mulligan LM, Ponder MA et al (1992) Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis. Genes Chromosomes Cancer 4:337–342PubMed
19.
go back to reference Upadhyaya M, Osborn M, Maynard J et al (1996) Characterization of six mutations in exon 37 of neurofibromatosis type 1 gene. Am J Med Genet 67:421–423PubMedCrossRef Upadhyaya M, Osborn M, Maynard J et al (1996) Characterization of six mutations in exon 37 of neurofibromatosis type 1 gene. Am J Med Genet 67:421–423PubMedCrossRef
20.
go back to reference Castle B, Baser ME, Huson SM et al (2003) Evaluation of genotype–phenotype correlations in neurofibromatosis type 1. J Med Genet 40:e109PubMedCrossRef Castle B, Baser ME, Huson SM et al (2003) Evaluation of genotype–phenotype correlations in neurofibromatosis type 1. J Med Genet 40:e109PubMedCrossRef
21.
go back to reference Ottini L, Esposito DL, Richetta A et al (1995) Alterations of microsatellites in neurofibromas of von Recklinghausen’s disease. Cancer Res 55:5677–5680PubMed Ottini L, Esposito DL, Richetta A et al (1995) Alterations of microsatellites in neurofibromas of von Recklinghausen’s disease. Cancer Res 55:5677–5680PubMed
22.
go back to reference Wang Q, Montmain G, Ruano E et al (2003) Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type. Hum Genet 112:117–123PubMed Wang Q, Montmain G, Ruano E et al (2003) Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type. Hum Genet 112:117–123PubMed
23.
go back to reference Ricciardone MD, Ozcelik T, Cevher B et al (1999) Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res 59:290–293PubMed Ricciardone MD, Ozcelik T, Cevher B et al (1999) Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res 59:290–293PubMed
24.
go back to reference Gallinger S, Aronson M, Shayan K et al (2004) Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. Gastroenterology 126:576–585PubMedCrossRef Gallinger S, Aronson M, Shayan K et al (2004) Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. Gastroenterology 126:576–585PubMedCrossRef
25.
go back to reference Kehrer-Sawatzki H, Tinschert S, Jenne DE (2003) Heterogeneity of breakpoints in non-LCR-mediated large constitutional deletions of the 17q11.2 NF1 tumour suppressor region. J Med Genet 40:e116PubMedCrossRef Kehrer-Sawatzki H, Tinschert S, Jenne DE (2003) Heterogeneity of breakpoints in non-LCR-mediated large constitutional deletions of the 17q11.2 NF1 tumour suppressor region. J Med Genet 40:e116PubMedCrossRef
Metadata
Title
Gastric carcinoid: germline and somatic mutation of the neurofibromatosis type 1 gene
Authors
W. Stewart
J. P. Traynor
A. Cooke
S. Griffiths
N. F. Őnen
M. Balsitis
A. A. Shah
M. Upadhyaya
E. S. Tobias
Publication date
01-03-2007
Publisher
Kluwer Academic Publishers
Published in
Familial Cancer / Issue 1/2007
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-006-9002-2

Other articles of this Issue 1/2007

Familial Cancer 1/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine